These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6171343)

  • 1. Selective activation of 5'-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index.
    Armstrong RD; Diasio RB
    Cancer Res; 1981 Dec; 41(12 Pt 1):4891-4. PubMed ID: 6171343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and biological activity of 5'-deoxy-5-fluorouridine, a novel fluoropyrimidine.
    Armstrong RD; Diasio RB
    Cancer Res; 1980 Sep; 40(9):3333-8. PubMed ID: 6253060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.
    Boothman DA; Briggle TV; Greer S
    Cancer Res; 1987 May; 47(9):2354-62. PubMed ID: 2952263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of fluoropyrimidines depends on the duration of thymidylate synthase inhibition in the murine colon 26-B carcinoma tumor model.
    van Laar JA; van der Wilt CL; Rustum YM; Noordhuis P; Smid K; Pinedo HM; Peters GJ
    Clin Cancer Res; 1996 Aug; 2(8):1327-33. PubMed ID: 9816304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precursor-dependent differences in the incorporation of fluorouracil in RNA.
    Takimoto CH; Cadman EC; Armstrong RD
    Mol Pharmacol; 1986 Jun; 29(6):637-42. PubMed ID: 2940459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes.
    Peters GJ; Laurensse E; Leyva A; Lankelma J; Pinedo HM
    Cancer Res; 1986 Jan; 46(1):20-8. PubMed ID: 2415245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cytotoxicity of 5'-deoxy-5-fluorouridine by prolonged culture with folinic acid.
    Matsuoka H; Furusawa M; Tomoda H; Seo Y; Sugimachi K
    Anticancer Res; 1993; 13(6A):2201-6. PubMed ID: 8297134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Fluorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity.
    Schuetz JD; Wallace HJ; Diasio RB
    Cancer Res; 1984 Apr; 44(4):1358-63. PubMed ID: 6704957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of L-histidinol on the metabolism of 5-fluorouracil in the BALB/c x DBA/8 F1 murine tumor system.
    Sawyer RC; Stolfi RL; Martin DS
    Cancer Res; 1988 Dec; 48(23):6664-8. PubMed ID: 2460227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of cytotoxic activity of 5'-deoxy-5-fluorouridine.
    Armstrong RD; Connolly KM; Kaplan AM; Cadman E
    Cancer Chemother Pharmacol; 1983; 11(2):102-5. PubMed ID: 6226452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in L1210 cells by fluoropyrimidine pretreatment.
    Grant S; Cadman E
    Cancer Res; 1982 Sep; 42(9):3550-6. PubMed ID: 6213294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonistic effect of polyinosinic-polycytidylic acid on the cell lethality produced by 5-fluorouracil in human colon carcinoma cells in vitro.
    Iigo M; Glazer RI
    Cancer Res; 1985 May; 45(5):1953-7. PubMed ID: 2580613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between ribosomal RNA production and RNA-directed fluoropyrimidine cytotoxicity.
    Takimoto CH; Tan YY; Cadman EC; Armstrong RD
    Biochem Pharmacol; 1987 Oct; 36(19):3243-8. PubMed ID: 2444230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.
    Roberts D; Franklin P; Odom G; Peck C; Chwang TL
    Mol Pharmacol; 1982 Nov; 22(3):760-5. PubMed ID: 6218391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydrofluorouracil, a fluorouracil catabolite with antitumor activity in murine and human cells.
    Diasio RB; Schuetz JD; Wallace HJ; Sommadossi JP
    Cancer Res; 1985 Oct; 45(10):4900-3. PubMed ID: 3928143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5'-Deoxy-5-fluorouridine selective toxicity for human tumor cells compared to human bone marrow.
    Armstrong RD; Cadman E
    Cancer Res; 1983 Jun; 43(6):2525-8. PubMed ID: 6221792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 5-fluorouracil metabolism in two human gastrointestinal tumor cell lines.
    Washtien WL
    Cancer Res; 1984 Mar; 44(3):909-14. PubMed ID: 6318987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of potentiation of antitumor activity of 5-fluoro-2'-deoxyuridine in the adenocarcinoma 755 system by guanosine 5'-monophosphate.
    Iigo M; Yamaizumi Z; Nakajima Y; Nishimura S; Hoshi A
    Drugs Exp Clin Res; 1988; 14(4):257-63. PubMed ID: 2458897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen and 5-fluorouracil in breast cancer: modulation of cellular RNA.
    Benz C; Santos G; Cadman E
    Cancer Res; 1983 Nov; 43(11):5304-8. PubMed ID: 6616465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of 5-fluorouracil into murine bone marrow DNA in vivo.
    Sawyer RC; Stolfi RL; Martin DS; Spiegelman S
    Cancer Res; 1984 May; 44(5):1847-51. PubMed ID: 6713387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.